IP And Trademarks 23 September 2026
India Patent & Trademark Surge: New Grants, Investor Meet, and Profit Dip
India sees a surge in patent activity across pharma, chemicals, packaging and tech, while the trademark registry grapples with many unregistered filings. An investor meet is set for Acutaas Chemicals, and Samsung India reports a 36% profit decline in FY26.
India Patent & Trademark Update
- Trademark registry backlog – many applications remain filed but not registered. Read more
- Acutaas Chemicals investor meet – scheduled at PL Capital conference on Sep 28. Details
- ENTOD Pharma insulin eye‑drop patent – granted Indian Patent No. 595378. Source
- Envoy Medical patents – new approvals in Canada and Hong Kong. Info
- UFlex aseptic packaging patent – 20‑year protection for high‑speed machine. Link
- TransCode approvals – patents granted in Australia and Japan. Read
- Lantern Pharma LP‑284 cancer drug – patent allowance received. Details
- Attero R&D centre – opened in Greater Noida for mineral recovery tech. Source
- Samsung India profit dip – down 36% to Rs 7,228 crore in FY26. Report
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.